Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris

Inclusion Criteria: * Males and females ≥ 12 years old. * Subjects must be in good general health as confirmed by medical history and physical examination. * Females of child-bearing potential must have a negative urine pregnancy test at the baseline visit and agree to be abstinent or use adequate birth control during the study (oral contraceptives, Norplant, Depo-Provera, or double barrier methods (e.g., condom and spermicide). * Clear diagnosis of facial acne vulgaris for at least 6 months. * Subject must have a static Physician's Global Assessment (PGA) of 2 (mild severity) or 3 (moderate severity). * Disease must be stable or slowly worsening for more than one week prior to entering the study. * Subjects or their guardians must be able to read, sign, and date the informed consent, and abide by study restrictions for its duration. Exclusion Criteria: * Females who are pregnant, attempting to conceive, or breastfeeding. * Subjects with known hypersensitivity to any ingredients in the study drugs. * Subjects with overt signs of skin atrophy, telangiectasias or other skin findings that would affect efficacy evaluation. * Subjects with a current active skin malignancy or infection. * Subjects requiring the use of medications known to alter the course of acne vulgaris during the study treatment. * Subjects who have received systemic antibiotics within 2 weeks. * Subjects using systemic corticosteroids or immunosuppressants within 28 days of entering the study. * Subjects who have received any topical therapies for acne vulgaris within 7 days of entering the study. * Subjects taking birth control pills used solely for acne control. * Subjects who are currently participating in or, within the previous 28 days, have participated in another study for the treatment of acne vulgaris. * Subjects with clinical conditions that may post a health risk to the subject by being involved in the study or detrimentally affect regular follow-up of the subject. * Subjects who have Crohn's disease, colitis, or if subjects ever developed colitis or severe diarrhea with past antibiotic use.